Trials Main Website

Trials
/
Frontotemporal Dementia (FTD)

COYA 302 for Frontotemporal Dementia (FTD)

Coming Soon

COYA 302

Phase 2 (Planned)

An upcoming clinical trial evaluating COYA 302 for the treatment of Frontotemporal Dementia.

Coya Therapeutics

A clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs) for neurodegenerative, autoimmune, and metabolic diseases.

Address: 5850 San Felipe St., Suite 500, Houston, TX 77057 USA

Phone: 1-800-587-8170

Email: clinicaltrials@coyatherapeutics.com

Follow Us

Quick Links

Main Website
Science & Technology
Patient Resources
Investor Relations

Legal

Privacy Policy
Terms & Conditions

© 2026 Coya Therapeutics, Inc. All rights reserved.

This website provides information about clinical research opportunities. The information on this site is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider about medical decisions.